Evidence map›Paper›PMID 26748507›Full record

ArticleDrug safety2016

Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.

Suzie Seabroke, Gianmario Candore, Kristina Juhlin, Naashika Quarcoo, Antoni Wisniewski, Ramin Arani, Jeffery Painter, Philip Tregunno, G Niklas Norén, Jim Slattery

Abstract read
PubMed Publisher
In one paragraph

Article in Drug safety, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. A Computational Framework for Identifying Age Risks in Drug-Adverse Event Pairs.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Suzie SeabrokeUK Medicines and Healthcare Products Regulatory Agency (MHRA), 151 Buckingham Palace Road, London, SW1W 9SZ, UK. suzie.seabroke@mhra.gsi.gov.uk.
Gianmario CandoreEuropean Medicines Agency, London, UK.
Kristina JuhlinUppsala Monitoring Centre, Uppsala, Sweden.
Naashika QuarcooGlaxoSmithKline, London, UK.
Antoni WisniewskiAstraZeneca, Alderley Park, UK.
Ramin AraniAstraZeneca, Alderley Park, UK.
Jeffery PainterGlaxoSmithKline, London, UK.
Philip TregunnoUK Medicines and Healthcare Products Regulatory Agency (MHRA), 151 Buckingham Palace Road, London, SW1W 9SZ, UK.
G Niklas NorénUppsala Monitoring Centre, Uppsala, Sweden.
Jim SlatteryEuropean Medicines Agency, London, UK.
AstraZeneca (United Kingdom) · GBGlaxoSmithKline (United Kingdom) · GBUppsala Monitoring Centre · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDisproportionality analyses are used in many organisations to identify adverse drug reactions (ADRs) from spontaneous report data. Reporting patterns vary over time, with patient demographics, and between different geographical regions, and therefore subgroup analyses or adjustment by stratification may be beneficial.

objectiveThe objective of this study was to evaluate the performance of subgroup and stratified disproportionality analyses for a number of key covariates within spontaneous report databases of differing sizes and characteristics.

methodsUsing a reference set of established ADRs, signal detection performance (sensitivity and precision) was compared for stratified, subgroup and crude (unadjusted) analyses within five spontaneous report databases (two company, one national and two international databases). Analyses were repeated for a range of covariates: age, sex, country/region of origin, calendar time period, event seriousness, vaccine/non-vaccine, reporter qualification and report source.

resultsSubgroup analyses consistently performed better than stratified analyses in all databases. Subgroup analyses also showed benefits in both sensitivity and precision over crude analyses for the larger international databases, whilst for the smaller databases a gain in precision tended to result in some loss of sensitivity. Additionally, stratified analyses did not increase sensitivity or precision beyond that associated with analytical artefacts of the analysis. The most promising subgroup covariates were age and region/country of origin, although this varied between databases.

conclusionsSubgroup analyses perform better than stratified analyses and should be considered over the latter in routine first-pass signal detection. Subgroup analyses are also clearly beneficial over crude analyses for larger databases, but further validation is required for smaller databases.

Indexed as

Adverse Drug Reaction Reporting SystemsDatabases, PharmaceuticalAdolescentAdultAgedChildChild, PreschoolDrug-Related Side Effects and Adverse ReactionsFemaleHumansInfantInfant, NewbornMaleMiddle AgedYoung Adult

Identifiers

PMID26748507
OpenAlexW2223304763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.